Abbott Laboratories logo

Abbott Laboratories

ABT | NYSE
Chart Builder DCF Calculator
$109.22
+$3.02 (+2.84%)
Nov 2, 2026, 12:40 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Net Income
6.52B 13.4B 5.72B 6.93B 7.07B 4.5B
Depreciation & Amortization
3.12B 3.22B 3.24B 3.27B 3.54B 3.33B
Stock-Based Compensation
664M 673M 644M 685M 640M 546M
Other Working Capital
-1.3B -8.82B -1.13B -458M -1.22B -1.24B
Other Non-Cash Items
65M 482M 126M 215M 55M 425M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a
Change in Working Capital
-803M -9.22B -2.48B -1.52B -771M -892M
Operating Cash Flow
9.57B 8.56B 7.26B 9.58B 10.53B 7.9B
Capital Expenditures
-2.17B -2.21B -2.2B -1.78B -1.89B -2.18B
Cash Acquisitions
-105M 1M -837M 48M -53M 16M
Purchase of Investments
-167M -169M -159M -185M -173M -83M
Sales Maturities Of Investments
3M 28M 43M 152M 77M 10M
Other Investing Acitivies
18M 9M 22M 22M 26M 19M
Investing Cash Flow
-2.42B -2.34B -3.13B -1.74B -2.01B -2.22B
Debt Repayment
-1.61B -537M -2.48B -699M -248M -50M
Common Stock Repurchased
-893M -1.3B -1.23B -3.8B -2.3B -403M
Dividend Paid
-4.12B -3.84B -3.56B -3.31B -3.2B -2.56B
Other Financial Acitivies
-82M 264M 167M 167M 255M 234M
Financial Cash Flow
-6.31B -5.4B -7.09B -7.64B -5.49B -2.78B
Net Cash Flow
906M 720M -2.99B 83M 2.96B 2.98B
Free Cash Flow
7.4B 6.35B 5.06B 7.8B 8.65B 5.72B
Adj. Free Cash Flow
6.73B 5.68B 4.42B 7.12B 8.01B 5.18B
Maintenance CapEx
-1.53B -1.72B -2.2B -1.63B n/a -1.43B
Growth CapEx
-641.58M -485.14M n/a -150.36M -1.89B -750.82M
Owner Earnings
8.04B 6.84B 5.06B 7.95B 10.53B 6.47B

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.